Connect with us

Government

The Ukraine’s Secret Weapon – Legalizing Medical Marijuana Immediately

Published

on

On the 7th of June 2022, a report from Viktor Lyashko, the Minister of Health revealed that Ukraine’s Cabinet of Ministers is in support of the bill that would enable cannabis-related drug firms to operate in the country. The mmj situation has been actively debated in Ukraine since 2017 when data suggests there’s been an increase in patients who need cannabis-based drugs. By 2021, the number has greatly increased with over 2 million people confirmed to need cannabis-based drugs. And now, considering the full-scale invasion of the country, the number has surged significantly.

The Cabinet of Ministers has now concluded that delaying the issue is no longer an option, especially with the Russian invasion going on now. This is why the Ukraine authority is establishing a legitimate framework that will monitor the production of marijuana-based drugs in the country. The government will actively monitor both the cultivation of cannabis and the production of resulting drugs.

The Ukraine government has also affirmed that experts are designing a mechanism to distribute and sell the drugs. Hence, there shouldn’t be concerns about drug trafficking as sales will be highly monitored and regulated. Viktor Lyashko, in a Facebook post, noted that the authorities recognize the negative impact of war on mental health. As such, they believe a lot of people will be needing medical treatment as a result of the war.

He further explained that opponents of the bill, who are against medical cannabis in the country intentionally compare illegal cannabis with cannabis-based medicines. He believes it is an attempt to negate the medical benefits of cannabis and to disprove its use in medicine.

The Purpose of the Bill

The bill aims to help promote quality medical services for individuals treating various health conditions using palliative medicine. The bill would also facilitate researchers to carry out more studies on the medical use of cannabis. Patients will also get more access to various treatments for over 50 health conditions courtesy of the bill. Patients who suffer from PTSD, chronic pain, cancer, and neurological diseases will have a chance for treatment once the bill is enacted.

Subsequently, the bill also put in place strict regulations and supervision over the growth, production, distribution, and sale of cannabis-based medical products. The bill will see to the licensing and authorization for the economic activities concerning the growth of cannabis strains for scientific research and medical purposes. This will also include a tracking system for medical cannabis to ensure adequate information of all stages of product distribution is recorded.

The bill will allow patients to buy cannabis-based medical products on a doctor’s prescription and according to the information displayed in the electronic prescription. The bill also grants a central executive unit the authority to determine THC levels in cannabis medical products via lab tests carried out by institutions, organizations, and enterprises.

The journey to medical cannabis legalization

The bill, in truth, has come a long way, having been initially tabled to the Ukrainian Parliament in June 2021. However, its first introduction to the house saw it rejected by the Verkhovna Rada of Ukraine a.k.a the Ukrainian Parliament. The lawmakers initially thought the bill would be approved given the legalization of the use of synthetic THC-based drugs, nabilone, dronabinol, and an iconols in April 2021. But to the lawmakers’ surprise, the Ukrainian Parliament kicked out the bill.

Before the war, a national survey was carried out by President Volodymyr Zelenskyy in October 2022. Information from the Ukrainian daily Kyiv Post suggests that the survey proved most Ukrainians to be in support of the organization of medical cannabis. When asked if they approve of medical cannabis legalization, 29.85% of respondents replied ‘no’, while 64.88% replied ‘yes’.

Evaluating the Facebook post from Mr. Liashko, it can be diseases that the war between Russia and Ukraine has boosted the process of medical cannabis legalization. He explained how the bill would establish situations for improving patients’ access to the needed treatment for conditions like cancer and PTSD as a result of the war.

The war invasion of Ukraine has exposed a lot of Ukrainians to huge post-traumatic stress disorder. Experts have warned that the war’s impact has already taken a major toll on young people, children, and the elderly, causing major psychological trauma.

Now more than three months of war and amid mental health breakdown in the country, the Ukrainian government came up with a solution – legalizing medical cannabis. They believe it may be the only option to help the citizens in their process of resilience.

According to the press statement delivered by the country’s Ministry of Health, initial evidence has proven that the use of cannabis-based medical drugs is effective in the treatment of mental disorders. With the stimulating and calming effect of cannabis on the human body, cannabis-based drugs have been proven to help treat anxiety, sleeping disorder, and PTSD.

The Ministry of Health now holds the position that Parliament should further support the bill, pointing out that medical cannabis will ease patients’ suffering and improve their mental state. On the other hand, adult use of cannabis will remain illegal in the country. Its cultivation, production, purchase, distribution, sale, and other recreational cannabis-related activities trigger penal or administrative violations.

Conclusion

Medical cannabis legalization in Ukraine does not translate to more accessibility for the average citizen. According to the bill, cannabis-based drugs will be highly monitored and controlled. The drugs can only be obtained by individuals who have medically confirmed diagnoses. Above all, the prescription will be electronic, making it virtually impossible to manipulate. Pharmaceutical chains will also be in charge of monitoring the sales and distribution of drugs while businesses that have to produce drugs from it will need to get a license.

It seems the Ukrainian government has everything planned out. Hopefully, medical cannabis will help relieve the stress of the war on the over 2 million citizens confirmed to need cannabis-based drugs. And above all, this will lead to the beginning of recreational cannabis reform in the country.

Source: https://cannabis.net/blog/news/the-ukraines-secret-weapon-legalizing-medical-marijuana-immediately

Business

New Mexico cannabis operator fined, loses license for alleged BioTrack fraud

Published

on

New Mexico regulators fined a cannabis operator nearly $300,000 and revoked its license after the company allegedly created fake reports in the state’s traceability software.

The New Mexico Cannabis Control Division (CCD) accused marijuana manufacturer and retailer Golden Roots of 11 violations, according to Albuquerque Business First.

Golden Roots operates the The Cannabis Revolution Dispensary.

The majority of the violations are related to the Albuquerque company’s improper use of BioTrack, which has been New Mexico’s track-and-trace vendor since 2015.

The CCD alleges Golden Roots reported marijuana production only two months after it had received its vertically integrated license, according to Albuquerque Business First.

Because cannabis takes longer than two months to be cultivated, the CCD was suspicious of the report.

After inspecting the company’s premises, the CCD alleged Golden Roots reported cultivation, transportation and sales in BioTrack but wasn’t able to provide officers who inspected the site evidence that the operator was cultivating cannabis.

In April, the CCD revoked Golden Roots’ license and issued a $10,000 fine, according to the news outlet.

The company requested a hearing, which the regulator scheduled for Sept. 1.

At the hearing, the CCD testified that the company’s dried-cannabis weights in BioTrack were suspicious because they didn’t seem to accurately reflect how much weight marijuana loses as it dries.

Company employees also poorly accounted for why they were making adjustments in the system of up to 24 pounds of cannabis, making comments such as “bad” or “mistake” in the software, Albuquerque Business First reported.

Golden Roots was fined $298,972.05 – the amount regulators allege the company made selling products that weren’t properly accounted for in BioTrack.

The CCD has been cracking down on cannabis operators accused of selling products procured from out-of-state or not grown legally:

Golden Roots was the first alleged rulebreaker in New Mexico to be asked to pay a large fine.

Source: https://mjbizdaily.com/new-mexico-cannabis-operator-fined-loses-license-for-alleged-biotrack-fraud/

Continue Reading

Business

Marijuana companies suing US attorney general in federal prohibition challenge

Published

on

Four marijuana companies, including a multistate operator, have filed a lawsuit against U.S. Attorney General Merrick Garland in which they allege the federal MJ prohibition under the Controlled Substances Act is no longer constitutional.

According to the complaint, filed Thursday in U.S. District Court in Massachusetts, retailer Canna Provisions, Treevit delivery service CEO Gyasi Sellers, cultivator Wiseacre Farm and MSO Verano Holdings Corp. are all harmed by “the federal government’s unconstitutional ban on cultivating, manufacturing, distributing, or possessing intrastate marijuana.”

Verano is headquartered in Chicago but has operations in Massachusetts; the other three operators are based in Massachusetts.

The lawsuit seeks a ruling that the “Controlled Substances Act is unconstitutional as applied to the intrastate cultivation, manufacture, possession, and distribution of marijuana pursuant to state law.”

The companies want the case to go before the U.S. Supreme Court.

They hired prominent law firm Boies Schiller Flexner to represent them.

The New York-based firm’s principal is David Boies, whose former clients include Microsoft, former presidential candidate Al Gore and Elizabeth Holmes’ disgraced startup Theranos.

Similar challenges to the federal Controlled Substances Act (CSA) have failed.

One such challenge led to a landmark Supreme Court decision in 2005.

In Gonzalez vs. Raich, the highest court in the United States ruled in a 6-3 decision that the commerce clause of the U.S. Constitution gave Congress the power to outlaw marijuana federally, even though state laws allow the cultivation and sale of cannabis.

In the 18 years since that ruling, 23 states and the District of Columbia have legalized adult-use marijuana and the federal government has allowed a multibillion-dollar cannabis industry to thrive.

Since both Congress and the U.S. Department of Justice, currently headed by Garland, have declined to intervene in state-licensed marijuana markets, the key facts that led to the Supreme Court’s 2005 ruling “no longer apply,” Boies said in a statement Thursday.

“The Supreme Court has since made clear that the federal government lacks the authority to regulate purely intrastate commerce,” Boies said.

“Moreover, the facts on which those precedents are based are no longer true.”

Verano President Darren Weiss said in a statement the company is “prepared to bring this case all the way to the Supreme Court in order to align federal law with how Congress has acted for years.”

While the Biden administration’s push to reschedule marijuana would help solve marijuana operators’ federal tax woes, neither rescheduling nor modest Congressional reforms such as the SAFER Banking Act “solve the fundamental issue,” Weiss added.

“The application of the CSA to lawful state-run cannabis business is an unconstitutional overreach on state sovereignty that has led to decades of harm, failed businesses, lost jobs, and unsafe working conditions.”

Source: https://mjbizdaily.com/marijuana-companies-suing-us-attorney-general-to-overturn-federal-prohibition/

Continue Reading

Business

Alabama to make another attempt Dec. 1 to award medical cannabis licenses

Published

on

Alabama regulators are targeting Dec. 1 to award the first batch of medical cannabis business licenses after the agency’s first two attempts were scrapped because of scoring errors and litigation.

The first licenses will be awarded to individual cultivators, delivery providers, processors, dispensaries and state testing labs, according to the Alabama Medical Cannabis Commission (AMCC).

Then, on Dec. 12, the AMCC will award licenses for vertically integrated operations, a designation set primarily for multistate operators.

Licenses are expected to be handed out 28 days after they have been awarded, so MMJ production could begin in early January, according to the Alabama Daily News.

That means MMJ products could be available for patients around early March, an AMCC spokesperson told the media outlet.

Regulators initially awarded 21 business licenses in June, only to void them after applicants alleged inconsistencies with how the applications were scored.

Then, in August, the state awarded 24 different licenses – 19 went to June recipients – only to reverse themselves again and scratch those licenses after spurned applicants filed lawsuits.

A state judge dismissed a lawsuit filed by Chicago-based MSO Verano Holdings Corp., but another lawsuit is pending.

Source: https://mjbizdaily.com/alabama-plans-to-award-medical-cannabis-licenses-dec-1/

Continue Reading

Trending

Copyright © 2022 420 Reports Marijuana News & Information Website | Reefer News | Cannabis News